Sudarshan Chemical Industries has announced the approval of stock options for its eligible employees and those of its subsidiaries. The Nomination and Remuneration Committee granted 98,458 options under Grant II and 199,670 options under Grant III of the Sudarshan Employee Stock Option Plan 2018. This action is in line with SEBI Listing Regulations and aims to align employee interests with the company’s performance.
Stock Option Grant Approved for Employees
Sudarshan Chemical Industries has officially approved the grant of stock options to its eligible employees and those of its subsidiaries. This decision was made by the company’s Nomination and Remuneration Committee on November 6, 2026, as part of the Sudarshan Employee Stock Option Plan 2018 (ESOP Plan).
Details of the Stock Option Grant
The disclosure, made under SEBI Listing Regulations, reveals that a total of 98,458 stock options under Grant II and 199,670 stock options under Grant III have been granted. These options cover a total of 298,128 equity shares, with each stock option equivalent to one equity share of a face value of ₹2/- each.
Grant II and Grant III Specifics
- Grant II Exercise Price: The exercise price for Grant II options is set at ₹2/- per stock option, which is equivalent to the face value.
- Grant III Exercise Price: For Grant III, the exercise price is determined by the latest available closing price on the stock exchange where the company’s shares have the highest trading volume, prior to the date of the Nomination and Remuneration Committee meeting where the options were granted.
Vesting and Exercise Period
The options are subject to a vesting schedule of 25% each year, commencing one year from the grant date, over a 4-year vesting period for both Grant II and Grant III. Employees will have a window of 3 years from the vesting date to exercise their options. The ESOP Plan is administered by the Nomination and Remuneration Committee, and equity shares arising from the exercise of these options will rank pari-passu with existing equity shares.
Sudarshan Chemical Industries has also uploaded this intimation on its official website, www.sudarshan.com, for public access.
Source: BSE
